Nanjing, China · Founded 2010 · Privately Held (backing)
Developer of innovative drugs designed to treat cardiovascular and cerebrovascular, tumors, endocrine, and other areas of chronic diseases. Jiangsu Vcare is based in Nanjing, China and was founded in 2010. Its last reported valuation was $162 million in Feb 2021. It has raised $225 million.
Last reported valuation
$162.4M
Oct 2026
Priced at
—
Total raised
$225.4M
Last round
—
Cap table — not yet on record
Jiangsu Vcare's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Jiangsu Vcare with a free account
·The complete investor list: 17 names
·Watch Jiangsu Vcare: the Monday email on marks, rounds and moves
